Skip to main content

Anti-HNE Michael Adducts Antibody, Reduced (C15-1317-518)

Catalog No.
C15-1317-518
Manufacturer No.
ABN249
Manufacturer Name
Sigma-Aldrich
Quantity
100
Unit of Measure
UL
Price: $759.43
List Price: $843.81

Reactive aldehydes generated during lipid peroxidation contribute to cell and tissue damage associated with oxidative stress. Alpha,beta-unsaturated carbonyl compounds such as 4-hydroxy-2-nonenal (HNE), 4-oxo-2-nonenal (ONE), and acrolein,

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account.

Adding to cart… The item has been added

General description

Reactive aldehydes generated during lipid peroxidation contribute to cell and tissue damage associated with oxidative stress. Alpha,beta-unsaturated carbonyl compounds such as 4-hydroxy-2-nonenal (HNE), 4-oxo-2-nonenal (ONE), and acrolein, generated from oxidation of polyunsaturated fatty acids (PUFAs), readily interact with nucleophilic groups on proteins, leading to intramolecular or intermolecular protein crosslinking. Two types of HNE modifications exist, the first type is formed by a 1:1 Michael adduct reaction with lysine amine, histine imidazole, or cysteine sulfhydryl, while the second type is produced by one HNE reacting simultaneously with two free amine groups from two N-alpha-acetyllysines (NALs), so-called Michael-Schiff base adduct. In the latter case, the initial nonfluorescent 2:1 lysine-HNE Michael adduct-Schiff base further undergoes oxidative cyclization to form a fluorescent 2-hydroxy-3-imino-1,2-dihydropyrrol derivative commonly referred to as HNE fluorophore. Reversibly formed HNE-Lys Michael adduct is not stable and reduction by sodium borohydride (NaBH4) is often employed to preserve Lys HNE mofidication in protein samples. Reductive stabilization by NaBH4 treatment is also used to prevent 4-HNE loss from 4-HNE-Cys Michael adduct by retro-Michael addition reaction (RMA) during collision-induced dissociation (CID) and electron transfer dissociation (ETD) MS/MS.

Specificity

Target modification is not species-specific.

This polyclonal antiserum detected HNE-modified BSA only after, but not before, reduction by sodium borohydride.

Immunogen

HNE-modifed KLH chemically reduced by sodium borohydride.

Application

Anti-HNE Michael Adducts Antibody, Reduced, Cat. No. ABN249, is a highly specific rabbit polyclonal antibody that targets the reduced form of 4-Hydroxy-2-noneal Michael adducts and has been tested in Western Blotting.

Application Notes:
1. ABN249 replaces Calbiochem 393207. ABN249 is expected to work in immunocytochemistry and immunohistochemistry. Please refer to the following 393207 citations as examples of sample preparations and detection in these two types of applications:

Usatyuk, P.V., et al. (2006). J. Biol. Chem. 281(46):35554-35566 (Immunocytochemistry).
McCormack, A.L., et al. (2005). J. Neurochem. 93(4):1030-1037 (Immunohistochemistry).

2. Anti-HNE Fluorophore, Cat. No. 393206, is also available for the detection of HNE Fluorophore by ELISA, Immunohistochemistry, and Western blotting.

3. To generate a positive control for Western blotting, treat a 2 mg/mL BSA solution in 10 mM KH2PO4, pH 7.4, with 0.1 to 0.5 mM HNE and incubate for 1 hr at 37°C. The reaction can be monitored by the decrease of HNE absorbance at 224 nm (extinction coefficient 13,750/M). Free HNE can be removed by gel filtration and dialysis following the chemical reaction.

HNE Michael adducts in protein solutions must be chemically reduced by sodium borohydride (NaBH4) prior to analysis using ABN1348. A freshly prepared 100 mM NaBH4 solution in 1 mM NaOH is added 1:9 (V:V) to the protein sample solution to a final NaBH4 concentration of 10 mM. The protein solution is kept at room temperature for 10 to 30 min prior to quenching with the addition of 5 to 10 molar equivalents of acetone.

Quality

Evaluated by Western Blotting in Reduced HNE-BSA.

Western Blotting Analysis: A 1:10,000 of this antibody detected 10 ng of HNE-modified BSA only after, but not before, reduction by sodium borohydride.

Target description

Variable depending on the size(s) of the HNE-modified protein(s). Uncharacterized bands may be observed in some lysate(s).

Linkage

Replaces: Calbiochem 393207

Analysis Note

Control
HNE-modifed BSA chemically reduced by sodium borohydride.

Other Notes

Concentration: Please refer to lot specific datasheet.

biological source: rabbit. Quality Level: 100. antibody form: serum. antibody product type: primary antibodies. clone: polyclonal. species reactivity: bovine, human. technique(s): western blot: suitable. shipped in: ambient. target post-translational modification: unmodified. Storage Class Code: 12 - Non Combustible Liquids. WGK: WGK 1. Flash Point(F): Not applicable. Flash Point(C): Not applicable.
UPC:
51201516
Condition:
New
Weight:
1.00 Ounces
HazmatClass:
No
WeightUOM:
LB
MPN:
ABN249


Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.


"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."

LAB DIRECTOR


"We utilized Cenmed's capabilities for a variety of projects around the world. They are a valued partner and supplier."

PHARMACEUTICAL SUPPLY CHAIN LEADER


"The reps are very good at finding products for customers in this period of supply chain issues."

SCOTT BEHMAN


"Your customer service has been excellent and makes me excited about purchasing with Cenmed in the future!!"

PROCUREMENT + BILLING COORDINATOR AT PHARMA.